Redburn Atlantic began coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report report ...

Sanofi SNY and partner, Alnylam Pharmaceuticals ALNY, announced that the FDA has approved Qfitlia (fitusiran) as the first ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") , a biotechnology company focused on the treatment and prevention of cancer, today announced its participation in the Jones Las Vegas Healthcare and ...

Persistent economic pressures and new U.S. policies, including proposed cuts to agencies like the National Institutes of Health (NIH) and tariffs on essential research materials, have led to mounting ...

Over the last 7 days, the United States market has dropped 3.4%, yet it remains up by 6.1% over the past year, with earnings anticipated to grow by 14% annually in the coming years. In this context, ...

Over the last 7 days, the United States market has dropped by 3.4%, but it has risen by 6.1% over the past year, with earnings forecasted to grow at an annual rate of 14%. In this context of ...